|
Volumn 44, Issue 12, 2003, Pages 1472-1478
|
Therapy Discovery for Pharmacoresistant Epilepsy and for Disease-modifying Therapeutics: Summary of the NIH/NINDS/AES Models II Workshop
f a b c d e g |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
BRAIN HYPOXIA;
BRAIN INJURY;
BRAIN ISCHEMIA;
BRAIN TUMOR;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
CONTINUING EDUCATION;
CORTICAL DYSPLASIA;
DISEASE MODEL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG SCREENING;
EPILEPSY;
EPILEPTIC STATE;
EPILEPTOGENESIS;
GENETIC DISORDER;
HEALTH;
HEALTH CARE ORGANIZATION;
HUMAN;
INFANTILE SPASM;
KINDLING;
LATENT PERIOD;
LENNOX GASTAUT SYNDROME;
NONHUMAN;
PARASITOSIS;
PRIORITY JOURNAL;
SEIZURE;
TEMPORAL LOBE EPILEPSY;
ANIMALS;
ANTICONVULSANTS;
CHRONIC DISEASE;
DISEASE MODELS, ANIMAL;
DRUG RESISTANCE;
EPILEPSY;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
STATUS EPILEPTICUS;
UNITED STATES;
|
EID: 0347364701
PISSN: 00139580
EISSN: None
Source Type: Journal
DOI: 10.1111/j.0013-9580.2003.32803.x Document Type: Conference Paper |
Times cited : (145)
|
References (0)
|